Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Jul;8(4):275-80.
doi: 10.1007/s11934-007-0073-x.

Hedgehog signaling in prostate growth and benign prostate hyperplasia

Affiliations
Review

Hedgehog signaling in prostate growth and benign prostate hyperplasia

Chad M Vezina et al. Curr Urol Rep. 2007 Jul.

Abstract

Hedgehog (Hh) signaling has long been recognized for its role in axial patterning, mesenchymal-epithelial inductive signaling, and growth regulation during fetal development. In many embryonic tissues, Hh functions as a proliferative stimulus. Sonic hedgehog and Indian hedgehog are both expressed by the urothelium of the fetal prostate anlage, where they regulate cell proliferation and differentiation and play a role in prostate ductal budding. Whereas Hh signaling in mouse prostate diminishes during adolescence and is maintained at a low level in the adult, robust Hh signaling is commonly found in the adult human prostate. The reason(s) for robust Hh signaling in the adult human prostate and the actions of Hh signaling on growth and differentiation in the adult are not well understood. However, increased Hh signaling has been associated with prostate cancer and has been shown to accelerate prostate cancer growth. These observations suggest that inappropriate reawakening of this developmental growth signal may play a pivotal role in prostate neoplasia. This review examines the role of Hh signaling during early prostate growth and in its corollary actions during prostate disease, including benign prostate hyperplasia and prostate cancer. The use of Hh inhibitors as a therapeutic modality for androgen-independent treatment of prostate disease is also discussed.

PubMed Disclaimer

References

    1. J Biol Chem. 2003 May 16;278(20):18506-13 - PubMed
    1. Mol Cancer. 2004 Oct 13;3:29 - PubMed
    1. Development. 2000 Jun;127(12):2763-72 - PubMed
    1. Cancer Res. 1994 Apr 1;54(7):1807-11 - PubMed
    1. Proc Natl Acad Sci U S A. 2005 May 10;102(19):6942-7 - PubMed

Substances

LinkOut - more resources